Penicillin allergy de-labelling
De-label · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Most recorded penicillin allergies are inaccurate, leading to inferior, broader-spectrum antibiotic use and worse outcomes. Structured allergy assessment, risk stratification and, where appropriate, direct oral challenge safely remove incorrect labels.
Red flags
- History of anaphylaxis to a beta-lactam
- Severe cutaneous adverse reaction (SJS/TEN, DRESS, AGEP)
- Organ involvement or mucosal blistering with prior reaction
- Reaction requiring adrenaline/ICU
- Positive specific IgE/skin test
Assessment
Differential diagnosis
- True IgE-mediated (type I) anaphylaxis
- Severe cutaneous adverse reaction (SJS/TEN, DRESS)
- Non-allergic intolerance (e.g. GI upset)
- Childhood viral rash mislabelled as allergy
- Unrelated symptom attributed to the drug
Investigations
- Detailed allergy history (reaction type, timing, severity, agent)
- Risk stratification into low vs high risk
- Specific IgE / skin testing in selected higher-risk cases
- Review of prior tolerated beta-lactams
- Documentation of any severe reaction features (blistering, mucosal, organ involvement)
- Observation setting for challenge if performed
Management
- Take a structured allergy history focusing on reaction phenotype and timing
- Identify and permanently avoid high-risk/severe reactions (anaphylaxis, SJS/TEN, DRESS)
- Risk-stratify remaining patients as low risk suitable for de-labelling
- For low-risk histories, offer direct oral amoxicillin challenge under observation
- Use skin testing/specialist referral for intermediate/higher-risk cases
- Observe after challenge for immediate and delayed reactions
- Update the allergy record clearly if tolerated
- Counsel the patient on the corrected status and future antibiotic use
- Educate that most cephalosporins are safe even with genuine penicillin allergy (low cross-reactivity)
- Avoid unnecessary second-line antibiotics once de-labelled
- Provide written confirmation of de-labelling
- Refer complex cases to allergy/immunology
Drugs & doses
Amoxicillin 250-500 mg PO as a single/graded direct oral challenge dose (low-risk patients)
Observation and resuscitation facilities available during challenge
Appropriate first-line beta-lactam reinstated once de-labelled
Adrenaline/anaphylaxis treatment available as a safety net
Disposition
Outpatient / inpatient allergy or antimicrobial stewardship service; refer severe/complex histories to allergy specialist.
Complications & pitfalls
- Breakthrough allergic reaction during challenge
- Re-labelling due to unrelated symptoms
- Missing a genuine severe allergy if history inadequate
- Ongoing harm from unaddressed incorrect labels (if not done)
- Anaphylaxis (rare) during testing
Exam pearls
- Around 9 in 10 penicillin allergy labels are not true allergy
- Direct oral challenge is safe and effective for low-risk histories
- Modern cephalosporins have low cross-reactivity with penicillins
- Never challenge a history of SJS/TEN, DRESS or anaphylaxis
- De-labelling improves antimicrobial stewardship and patient outcomes
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.